Market Tracker

10/22 9:53am ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.64
Data as of 9:35am ET
 -0.06 / -1.28%
Today’s Change
3.10
Today|||52-Week Range
7.45
-12.95%
Year-to-Date

Today’s Trading

Previous close4.70
Today’s open4.78
Day’s range4.64 - 4.81
Volume603,785
Average volume (3 months)916,918
Market cap$333.9M
Dividend yield--
Data as of 9:35am ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+97.37%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.03+0.38%
XNCRXencor Inc0.000.00%
SNTASynta Pharmaceutical...+0.02+0.65%
PTXPernix Therapeutics ...-0.04-0.44%
Data as of 9:51am ET, 10/22/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts